메뉴 건너뛰기




Volumn 142, Issue 3, 2005, Pages 182-186

Responding to the rofecoxib withdrawal crisis: A new model for notifying patients at risk and their health care providers

Author keywords

[No Author keywords available]

Indexed keywords

ROFECOXIB;

EID: 13244265911     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-3-200502010-00008     Document Type: Article
Times cited : (20)

References (31)
  • 1
    • 84882464229 scopus 로고    scopus 로고
    • FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws the Product
    • 30 September. on 30 September 2004
    • U.S. Food and Drug Administration. FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws the Product. FDA News. 30 September 2004. Accessed at www.fda.gov/bbs/topics/news/2004/NEW01122.html on 30 September 2004.
    • (2004) FDA News
  • 2
    • 4944229572 scopus 로고    scopus 로고
    • Merck withdraws arthritis drug worldwide
    • Singh D. Merck withdraws arthritis drug worldwide. BMJ. 2004;329:816.
    • (2004) BMJ , vol.329 , pp. 816
    • Singh, D.1
  • 3
    • 6044267892 scopus 로고    scopus 로고
    • Failing the public health - Rofecoxib, Merck, and the FDA
    • Topol EJ. Failing the public health - rofecoxib, Merck, and the FDA. N Engl J Med. 2004;351:1707-9.
    • (2004) N Engl J Med , vol.351 , pp. 1707-1709
    • Topol, E.J.1
  • 5
    • 7044246370 scopus 로고    scopus 로고
    • Whitehouse Station, NJ: Merck & Co., Inc.; on 30 September 2004
    • Merck announces voluntary worldwide withdrawal of VIOXX®. News release. Whitehouse Station, NJ: Merck & Co., Inc.; 2004;1-3. Accessed at www.vioxx.com/rofecoxib/vioxx/consumer/index.jsp on 30 September 2004.
    • (2004) Merck Announces Voluntary Worldwide Withdrawal of VIOXX®. News Release , pp. 1-3
  • 6
    • 0036904515 scopus 로고    scopus 로고
    • Drug safety withdrawals: Who is responsible for notifying patients?
    • Wolfe SM. Drug safety withdrawals: who is responsible for notifying patients? [Editorial] Pharmacoepidemiol Drug Saf. 2002;11:641-2.
    • (2002) Pharmacoepidemiol Drug Saf , vol.11 , pp. 641-642
    • Wolfe, S.M.1
  • 7
    • 0034183399 scopus 로고    scopus 로고
    • Drug recalls underscore safety concerns
    • Greene HL. Drug recalls underscore safety concerns. Health News. 2000;6:4.
    • (2000) Health News , vol.6 , pp. 4
    • Greene, H.L.1
  • 8
    • 0029062698 scopus 로고
    • Wanted: Timely receipt of drug-recall information
    • author reply 1011-2
    • Lima HA, Fisk RA. Wanted: timely receipt of drug-recall information [Letter]. Am J Health Syst Pharm. 1995;52:1010-1; author reply 1011-2.
    • (1995) Am J Health Syst Pharm , vol.52 , pp. 1010-1011
    • Lima, H.A.1    Fisk, R.A.2
  • 9
    • 0037103301 scopus 로고    scopus 로고
    • Contacting patients of a Pakistani hospital about a drug recall
    • Zaidi ST, Sheikh AL, Raza SS. Contacting patients of a Pakistani hospital about a drug recall [Letter]. Am J Health Syst Pharm. 2002;59:1569.
    • (2002) Am J Health Syst Pharm , vol.59 , pp. 1569
    • Zaidi, S.T.1    Sheikh, A.L.2    Raza, S.S.3
  • 10
    • 0030953419 scopus 로고    scopus 로고
    • Lessons from the influenza vaccine recall of 1996-1997
    • Poland GA. Lessons from the influenza vaccine recall of 1996-1997. JAMA. 1997;278:1022-3.
    • (1997) JAMA , vol.278 , pp. 1022-1023
    • Poland, G.A.1
  • 11
    • 0036905577 scopus 로고    scopus 로고
    • High rates of adverse effects and patient unawareness of withdrawn lipid-lowering drug combination in a public hospital clinic
    • Schiff GD, Keehr LM, Sai TT, Bult J. High rates of adverse effects and patient unawareness of withdrawn lipid-lowering drug combination in a public hospital clinic. Pharmacoepidemiol Drug Saf. 2002;11:643-5.
    • (2002) Pharmacoepidemiol Drug Saf , vol.11 , pp. 643-645
    • Schiff, G.D.1    Keehr, L.M.2    Sai, T.T.3    Bult, J.4
  • 12
    • 1542613779 scopus 로고    scopus 로고
    • Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication
    • Delorio NM. Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication. J Emerg Med. 2004;26:305-7.
    • (2004) J Emerg Med , vol.26 , pp. 305-307
    • Delorio, N.M.1
  • 13
    • 0035802056 scopus 로고    scopus 로고
    • Physician liability and drug recalls
    • Johnson LJ. Physician liability and drug recalls. Med Econ. 2001;78:118.
    • (2001) Med Econ , vol.78 , pp. 118
    • Johnson, L.J.1
  • 14
    • 0029246686 scopus 로고
    • Competence assessment; requirements of a drug recall system; dealing with ethical issues
    • Rich DS. Competence assessment; requirements of a drug recall system; dealing with ethical issues. Hosp Pharm. 1995;30:165-71.
    • (1995) Hosp Pharm , vol.30 , pp. 165-171
    • Rich, D.S.1
  • 15
    • 13244272558 scopus 로고    scopus 로고
    • Zix Corporation's e-prescribing application helps physicians with vioxx recall
    • 4 October. on 11 October 2004
    • Zix Corporation's e-prescribing application helps physicians with vioxx recall. Forbes Business Wire. 4 October 2004. Accessed at www.forbes.com/ businesswire/feeds/businesswire/2004/10/04/businesswire20041004005144r1.html on 11 October 2004.
    • (2004) Forbes Business Wire
  • 22
    • 0034707105 scopus 로고    scopus 로고
    • Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
    • VIGOR Study Group. 2 p following 1528
    • Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000;343:1520-8, 2 p following 1528.
    • (2000) N Engl J Med , vol.343 , pp. 1520-1528
    • Bombardier, C.1    Laine, L.2    Reicin, A.3    Shapiro, D.4    Burgos-Vargas, R.5    Davis, B.6
  • 23
    • 85007729496 scopus 로고    scopus 로고
    • Is the FDA approving drugs too fast? Probably not - But drug recalls have sparked debate
    • Kleinke JD, Gottlieb S. Is the FDA approving drugs too fast? Probably not - but drug recalls have sparked debate [Editorial]. BMJ. 1998;317:899.
    • (1998) BMJ , vol.317 , pp. 899
    • Kleinke, J.D.1    Gottlieb, S.2
  • 24
    • 0033549140 scopus 로고    scopus 로고
    • The safety of new medicines: The importance of asking the right questions
    • Wood AJ. The safety of new medicines: the importance of asking the right questions [Editorial]. JAMA. 1999;281:1753-4.
    • (1999) JAMA , vol.281 , pp. 1753-1754
    • Wood, A.J.1
  • 25
    • 0033549087 scopus 로고    scopus 로고
    • The safety of newly approved medicines: Do recent market removals mean there is a problem?
    • Friedman MA, Woodcock J, Lumpkin MM, Shuren JE, Hass AE, Thompson LJ. The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA. 1999;281:1728-34.
    • (1999) JAMA , vol.281 , pp. 1728-1734
    • Friedman, M.A.1    Woodcock, J.2    Lumpkin, M.M.3    Shuren, J.E.4    Hass, A.E.5    Thompson, L.J.6
  • 26
    • 0032556180 scopus 로고    scopus 로고
    • Effect of computerized physician order entry and a team intervention on prevention of serious medication errors
    • Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311-6.
    • (1998) JAMA , vol.280 , pp. 1311-1316
    • Bates, D.W.1    Leape, L.L.2    Cullen, D.J.3    Laird, N.4    Petersen, L.A.5    Teich, J.M.6
  • 27
    • 0037663736 scopus 로고    scopus 로고
    • Effects of computerized physician order entry and clinical decision support systems on medication safety: A systematic review
    • Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med. 2003;163:1409-16.
    • (2003) Arch Intern Med , vol.163 , pp. 1409-1416
    • Kaushal, R.1    Shojania, K.G.2    Bates, D.W.3
  • 29
    • 3242758259 scopus 로고    scopus 로고
    • Users of Internet health information: Differences by health status
    • Houston TK, Allison JJ. Users of Internet health information: differences by health status. J Med Internet Res. 2002;4:E7.
    • (2002) J Med Internet Res , vol.4
    • Houston, T.K.1    Allison, J.J.2
  • 30
    • 0344341695 scopus 로고
    • The incidence of limb and ear defects since the withdrawal of thalidomide
    • Smithells RW. The incidence of limb and ear defects since the withdrawal of thalidomide. Lancet. 1963:1:1095-7.
    • (1963) Lancet , vol.1 , pp. 1095-1097
    • Smithells, R.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.